Congressional panel wants better cooperation in opioid investigation
HUNTINGTON — Congressional representatives in Washington, D.C., this week called for better cooperation from government agencies as they prepare for Feb. 26 congressional hearings on the role of prescription drug distribution in the opioid epidemic.
The congressional Energy and Commerce Committee is continuing its investigation into the opioid epidemic.
Bipartisan leaders held a press conference Tuesday ahead of the Feb. 26 hearings, during which they said the Drug Enforcement Administration and Department of Justice are being uncooperative with their investigation, despite numerous requests for basic information, Committee Chairman Greg Walden, R-Ore., said.
“We worked with the DEA at every turn, believing that we could be partners in this effort. We should be partners in this effort. But to our surprise and dismay, DEA has all but stonewalled our investigation,” Walden said. “We are done waiting for their cooperation.”
Walden said the original purpose of the committee’s probe of the DEA was to gain a better understanding of key systems.